Adaptive Biotechnologies Corp (ADPT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Chad Robins
Employees:
1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA 98102
206-659-0067

Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.

Data derived from most recent annual or quarterly report
Market Cap 1.092 Billion Shares Outstanding141.584 Million Avg 30-day Volume 1.821 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.4
Price to Revenue25.7402 Debt to Equity0.0 EBITDA-187.78 Million
Price to Book Value6.5776 Operating Margin-135.3898 Enterprise Value3.403 Billion
Current Ratio3.539 EPS Growth-0.333 Quick Ratio3.255
1 Yr BETA 2.1122 52-week High/Low 43.4 / 6.2 Profit Margin-134.3091
Operating Cash Flow Growth-28.7568 Altman Z-Score6.1726 Free Cash Flow to Firm -158.438 Million
Earnings Report2022-08-03

Are you looking for this stock instead?

View SEC Filings from ADPT instead.

View recent insider trading info

Funds Holding ADPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

831 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ADAMS R MARK CHIEF OPERATING OFFICER

  • Officer
122,893 2022-04-07 7

LO FRANCIS CHIEF PEOPLE OFFICER

  • Officer
92,088 2022-03-08 2

BALDO LANCE CHIEF MEDICAL OFFICER

  • Officer
17,171 2022-03-08 2

TAYLOR STACY L SVP AND GENERAL COUNSEL

  • Officer
72,859 2022-03-08 6

ROBINS CHAD M CEO AND CHAIRMAN

  • Officer
  • Director
8,059,572 2022-03-07 5

PISKEL KYLE PRINCIPAL ACCOUNTING OFFICER

  • Officer
198,515 2022-03-04 3

RUBINSTEIN JULIE PRESIDENT

  • Officer
920,983 2022-03-04 1

ROBINS HARLAN S CHIEF SCIENTIFIC OFFICER

  • Officer
1,246,229 2022-03-04 8

BENZENO SHARON CHIEF BUSINESS DEVELOPMENT OFF

  • Officer
413,793 2022-03-04 1

SOOD NITIN CHIEF COMMERCIAL OFFICER

  • Officer
327,856 2022-03-04 3

GRIFFIN MICHELLE RENEE

  • Director
24,915 2022-01-26 5

NEUPERT PETER M

  • Director
24,915 2022-01-26 1

HERSHBERG ROBERT

  • Director
24,915 2022-01-26 1

TRIGG LESLIE

  • Director
27,854 2022-01-26 1

CONROY KEVIN T

  • Director
24,915 2022-01-26 1

PELLINI MICHAEL J

  • Director
24,915 2022-01-26 1

OWEN KATEY EINTERZ

  • Director
27,854 2022-01-26 1

COHEN CHAD M CHIEF FINANCIAL OFFICER

  • Officer
101,604 2021-12-22 7

PALANIAPPAN JYOTI SVP, DIAGNOSTICS, T-DETECT

  • Officer
113,551 2021-07-19 2

THORSEN HENNING SVP, COMMERCIAL OPERATIONS

  • Officer
101,714 2021-05-17 0

GOEL DAVID E.

MATRIX CAPITAL MANAGEMENT COMPANY, LP

  • Director
  • SEE REMARKSSEE REMARKS
12,310,594 2021-03-08 0

BOBULSKY SUSAN SVP, DIAGNOSTICS, CLONOSEQ

  • Officer
32,052 2021-03-04 0

GOEL DAVID E.

  • Director
1,504 2021-02-15 0

DOBMEIER ERIC

  • Director
1,504 2021-02-14 0

HILL NANCY LOUISE EVP, OPERATIONS & PROGRAM MANA

  • Officer
23,200 2021-01-19 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES II LP

VIKING GLOBAL EQUITIES MASTER LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
29,993,708 2020-12-14 0

SANG CHARLES SVP, EXTERNAL AFFAIRS

  • Officer
0 2020-12-11 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
30,993,708 2020-11-11 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES II LP

VIKING GLOBAL EQUITIES MASTER LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
30,993,708 2020-11-11 0

ZOLTNERS ANDRIS A

  • Director
0 2020-02-13 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES MASTER LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
38,406,607 2019-07-01 0

SPH GROUP HOLDINGS LLC

STEEL PARTNERS HOLDINGS L.P.

STEEL PARTNERS LLC

LICHTENSTEIN WARREN G PRESIDENT OF SUBSIDIARY

SPH GROUP LLC

  • Officer
  • Director
  • 10% Owner
41,031,674 2011-09-27 0

STEEL PARTNERS II LP

STEEL PARTNERS LLC

LICHTENSTEIN WARREN G PRESIDENT OF SUBSIDIARY

STEEL PARTNERS HOLDINGS L.P.

  • Officer
  • Director
  • 10% Owner
37,094,472 2011-05-27 0

STEEL PARTNERS II LP

STEEL PARTNERS LLC

LICHTENSTEIN WARREN G

STEEL PARTNERS HOLDINGS L.P.

STEEL PARTNERS II GP LLC

  • 10% Owner
23,469,843 2009-12-16 0

DOTZ MARY CHIEF FINANCIAL OFFICER

  • Officer
85,000 2009-02-18 0

SUNDARESH SUBRAMANIAN PRESIDENT & CEO

  • Officer
333,518 2009-02-18 0

STEEL PARTNERS II LP

STEEL PARTNERS LLC

LICHTENSTEIN WARREN G

STEEL PARTNERS II GP LLC

STEEL PARTNERS II MASTER FUND L.P.

  • 10% Owner
23,171,338 2008-11-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ADAMS R MARK - Officer CHIEF OPERATING OFFICER

2022-04-08 20:00:16 -0400 2022-04-07 S 831 $13.17 d 122,893 direct -0.4979 -14.1909 0.0 1 -14.2739 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 22:15:03 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 21:45:03 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 21:15:03 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 20:45:03 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 20:15:05 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 19:45:03 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 19:15:04 UTC 0.3917 0.4283 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 18:45:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 18:15:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 17:45:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 17:15:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 16:45:04 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 16:15:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 15:45:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 15:15:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 14:45:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 14:15:04 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 13:45:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 13:15:03 UTC 0.3925 0.4275 1300000
ADAPTIVE BIOTECHNOLOGIES ADPT 2022-05-20 12:45:03 UTC 0.3925 0.4275 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advisors Series Trust- Pzena Long/Short Value Fund ADPT -3381.0 shares, $-130844.7 2020-05-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund ADPT -28.0 shares, $-777.84 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund ADPT -62.0 shares, $-3015.06 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ADPT -89.0 shares, $-2472.42 2020-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund ADPT -5653.0 shares, $-227589.78 2021-03-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund ADPT -5300.0 shares, $-200393.0 2021-05-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund ADPT -1900.0 shares, $-77634.0 2021-06-30 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund ADPT -3876.0 shares, $-142094.16 2021-07-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund ADPT -2900.0 shares, $-98571.0 2021-09-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio ADPT -36600.0 shares, $-1244034.0 2021-09-30 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund ADPT -1061.0 shares, $-27681.49 2021-11-30 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund ADPT -3273.0 shares, $-91840.38 2021-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ADPT -100.0 shares, $-2806.0 2021-12-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund ADPT -9759.0 shares, $-273837.54 2021-12-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND ADPT -4893.0 shares, $-85333.92 2022-01-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund ADPT -314.0 shares, $-5476.16 2022-01-31 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity ETF ADPT -1708.0 shares, $-24646.44 2022-02-28 N-PORT
First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF ADPT -11896.0 shares, $-207466.24 2022-01-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund ADPT -179.0 shares, $-2484.52 2022-03-31 N-PORT

Elevate your investments